EFDID: 41609EFD: View Filing

Issuer: Genesis Biopharma, Inc (0001425205) - D

Accession: 0001144204-11-044671 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001425205
  • Entity Name:
    Genesis Biopharma, Inc
  • Entity Type:
    Corporation
  • Jurisdiction:
    NEVADA
  • Year of Inc:
    Within 5 years (2007)
  • Address:
    11500 OLYMPIC BOULEVARD
    SUITE 400
    LOS ANGELES, CA 90064
  • Persons:
    Related Persons 7
    Anthony Cataldo
    Executive OfficerDirector
    Michael Handelman
    Executive OfficerDirector
    Dr. L. Stephen Coles
    Director
    Dr. William Andrews
    Director
    Merrill A. McPeak
    Director
    Martin Schroeder
    Director
    David Voyticky
    Director
EDGAR: Offering Information
  • Accession Date:
    08/09/2011
  • First Sale Date:
    07/27/2011
  • Offering Amount:
    $5,000,000
  • Amount Sold:
    $5,000,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Debt
  • Sales Clarification:
    *Of the $5,000,000 subscribed to, $2,500,000 is held in escrow per terms of an Escrow Agreement. Funds to be released to Issuer provided it executes a worldwide non-exclusive license to certain intellectual property owned by the U.S. Government
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Canaccord Genuity, Inc. 1020 None None CA
Cowen and Company LLC 7616 None None CA
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Genesis Biopharma, IncMichael Handelman/s/ Michael HandelmanChief Financial Officer and Director2011-08-09